CAPITOL COUNSEL LLC

Lobbying for DISC MEDICINE · Biotech Company focused on developing therapies for rare diseases.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $50,000.00 income · posted Apr 16, 2026

Lobbying activity 2

Health Issues

Engagement with Congress regarding FDA approvals for rare diseases.

Medicare/Medicaid

Engagement with Congress regarding FDA approvals for rare diseases.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.